Join to View Full Profile
1959 Ne Pacific StC212, Box 356340Seattle, WA 98195
Phone+1 206-543-0065
Are you Dr. Hoofnagle?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Andrew Hoofnagle, MD is a board certified pathologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is an Assistant Professor at University of Washington School.
Education & Training
University of WashingtonResidency, Pathology-Anatomic and Clinical, 2004 - 2007
University of Colorado School of Medicine Anschutz Medical CampusClass of 2004
Certifications & Licensure
WA State Medical License 2006 - 2025
American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- Molecular Phenotyping With Proteomics.Devin K Schweppe, Brian J Beliveau, Andrew N Hoofnagle
JAMA. 2025-03-11 - High-Density Lipoprotein Lipidomics, Endothelial Dysfunction, and Fistula Maturation in Patients With Advanced Chronic Kidney Disease.Benjamin Lidgard, Andrew N Hoofnagle, Leila R Zelnick, Ian H de Boer, Amanda M Fretts
Kidney Medicine. 2025-03-01 - Serum free 25(OH)D concentrations and cardiovascular disease, heart failure, kidney function decline, and fracture: the health, aging, and body composition study.Jonathan H Cheng, Andrew N Hoofnagle, Ronit Katz, Stephen B Kritchevsky, Michael G Shlipak
JBMR Plus. 2025-03-01
Press Mentions
Home Blood Collection Device Works for COVID Antibody TestSeptember 3rd, 2021
You Need Vitamin D to Live. How Could This Woman Survive with None in Her Blood?April 13th, 2019
Cannabis Legalization Does Not Influence Patient Compliance with Opioid TherapyMarch 3rd, 2019- Join now to see all
Grant Support
- Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environmentFRED HUTCHINSON CANCER CENTER2023–2028
- Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetesUNIVERSITY OF WASHINGTON2023–2027
